Selection procedure reference: EMA/TR/11124
Deadline for applications: 30 September 2025 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 30 September 2025 23:59 CET, with an intake on 1 March 2026.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master’s students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Evaluation and Innovation support Department within Veterinary Medicines Division.
Specific objectives and projects
During this taineeship, the selected trainee will conduct a comprehensive review of current literature and other relevant available information to identify new and re-emerging animal pathogens and available tools for control.
The project will also include an assessment of the effectiveness and accesibility of existing vaccines and treatments and identify gaps in current preventive and therapeutic measures.
The final derivable will be a list of relevant diseases prioritised according to importance for animal and public health, including the available control tools (with special focus on vaccines). This will allow to identify existing gaps and reflect on the role of the Agency to support the development and authorisation of products. The outcome could be published in the Agency website and/or a scientific or regulatory publication.
This project aims to identify emerging animal diseases and other relevant diseases of importance for animal (and potentially human) health and carry out a gap analysis to prioritise these, based on defined parameters, and to evaluate the availability of vaccines (both centrally and nationally authorised) and (possibly) other therapeutic measures to treat or prevent these diseases, within the One Health context.
Learning outcomes

Through this traineeship, the trainee will :

• improve his/her knowledge in toxicology, and in the classification of active substances used in medicines.
• gain knowledge of the legislative frameowork related to the safety of veterinary medicines for the consumers of food of animal origin
• gain experience of reviewing and understanding scientific regulatory reports
• gain experience of working in a multicultural, multidisciplinary environment

Eligibility criteria

WHO WE ARE?

Serving a population of 500 million citizens, we promote and protect public animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.

Please refer the Job description for details